Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
Chadwick W ChristineR Mark RichardsonAmber D Van LaarElisabeth M FineOmar S KhwajaGrace S LiangKrystof BankiewiczPaul S LarsonPublished in: Neurology (2022)